CAMBRIDGE, Mass., March 23, 2021 /PRNewswire/ -- nference, the AI-driven health technology company, today announced publication in EClinicalMedicine of study "Pre-existing conditions are associated ...

CAMBRIDGE, Mass., May 4, 2021 /PRNewswire/ -- nference, the AI-driven health technology company, today announced that it has been named as a finalist in the Fast Company World Changing Ideas Awards in ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--nference, a science-first software company transforming healthcare data for research and discovery, and Emory Healthcare, the most comprehensive academic health ...

Nference has raised $60 million. The Mayo Clinic-backed series B round positions nference to forge ahead with its effort to capture and analyze health data, including unstructured information, to help ...

It’s been a good end to the year for data analytics firm nference, ending the year as it started: with a $60 million funding round and a deal with the Mayo Clinic. Back in January, Massachusetts-based ...

nference’s federated AI platform is being leveraged to provide access to the deepest clinical data to generate insights and better inform decision-making CAMBRIDGE, Mass.--(BUSINESS WIRE)--nference, a ...

CAMBRIDGE, Mass., April 17, 2025 /PRNewswire/ -- nference, a company dedicated to transforming healthcare by making biomedical data computable, today announced a collaboration with BeiGene, Ltd, a ...

EHR data company nference on Wednesday launched its real-world evidence generation platform and expanded its existing partnership with the Mayo Clinic. The platform, dubbed nSights, collects ...

-- One third of patients taking immediate-release, twice-nightly sodium oxybate discontinued treatment, most often due to lack of efficacy; inability to wake up was most common reason for missing ...

Durham, N.C.-based Duke Health has partnered with data analytics company Nference to advance the academic health system’s research and medical discoveries. Nference has previously collaborated with ...

CAMBRIDGE, Mass. & LEXINGTON, Mass., March 18, 2025--(BUSINESS WIRE)--Valo Health, Inc. ("Valo"), a biotechnology company focused on transforming the drug discovery and development process using human ...